Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NEUVÉ Health vs YourHealthRx

NEUVÉ Health
Graded #246

Lower grade

vs+4.9
YourHealthRx
Graded #130

Higher grade

The verdict

YourHealthRx takes it — 69.6/100 to 64.7/100.

YourHealthRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueYourHealthRx +4
49
53
Dose & formulationEven
75
75
Clinical oversightYourHealthRx +18
69
87
Labs & monitoringNEUVÉ Health +6
73
67
FulfillmentYourHealthRx +18
76
94
Contract termsNEUVÉ Health +12
45
33
NEUVÉ Health · left barYourHealthRx · right bar

The numbers

MetricNEUVÉ HealthYourHealthRx
WeighScore64.7/10069.6/100
GradeCC
Scorecard rank#246#130
Semaglutide$179/mo (injectable microdose with B12; the site gives three answers on whether medication is included)$170/mo (compounded)
Tirzepatide$240/mo (injectable microdose with B12; the site gives three answers on whether medication is included)$210/mo (compounded)
CoverageAll 50 states (claimed; the same page says members in 40+ states)All 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
NEUVÉ Health

Graded #246 · C

Strengths

  • The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
  • Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
  • States both compounding classes on the homepage rather than leaving the question open
  • Names clinicians on the site and inside the matching step of the intake
  • A large hormone, peptide and lab menu sits beside the GLP-1 lines

Where it loses points

  • Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
  • Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
  • Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
  • The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
  • Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
  • “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
  • Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
YourHealthRx

Graded #130 · C

Strengths

  • Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
  • Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
  • Flat subscription price that doesn't change as your dose increases (no titration penalty)
  • Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
  • Transparent, education-first positioning with published medical disclaimer, privacy, and terms

Where it loses points

  • Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
  • Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard